Fragmentation in the healthcare industry's supply chain inhibits the ability to evaluate clinical efficacy of purchased supplies, as well as identify opportunities to improve efficiency.
U.S. manufacturing isn't likely return to prerecession levels for at least year and a half largely because the sector is grappling with weak demand for American exports and federal government cutbacks.